Nitric Oxide and Cyclic GMP-Mediated Protein Secretion from Cultured Lacrimal Gland Acinar Cells

Journal of Ocular Pharmacology and Therapeutics

Volumn 18, Issue 5, 2002, Pages 429-443

  Beauregard, Clay ^a   Brandt, Paul C ^a   Chiou, George C Y ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; BENZOYLARGININE ETHYL ESTER; CANAVANINE; CARBACHOL; CYCLIC GMP; GUANYLATE CYCLASE; HYDRALAZINE; ISOSORBIDE DINITRATE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; ENZYME INHIBITOR; EYE PROTEIN; NITRIC OXIDE;

ACINAR CELL; ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; LACRIMAL GLAND; NONHUMAN; PROTEIN SECRETION; RABBIT; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; LACRIMAL APPARATUS; SECRETION;

ANIMALS; CELL LINE, TRANSFORMED; CYCLIC GMP; ENZYME INHIBITORS; EYE PROTEINS; LACRIMAL APPARATUS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; RABBITS;

EID: 0036779519     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/10807680260362713     Document Type: Article

References (27)

1. Foulks, G.N. The now and future therapy of the non-Sjögren's dry eye. Adv. Exp. Med. Biol. 438:959-964, 1998.
2. Dartt, D.A. and Botelho, S.Y. Protein in rabbit lacrimal gland fluid. Invest. Ophthalmol. Vis. Sci. 18:1207-1219, 1979.
3. Stern, M.E., Beuerman, R.W., Fox, R.I., Gao, J., Mircheff, A.K. and Pfugfelder, S.C. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 17:584-589, 1998.
4. Sullivan, D.A., Wickham, L.A., Rocha, E.M., Kelleher, R.S., da Silviera, L.A. and Toda, I. Influence of gender, sex steroid hormones, and the hypothalamic-pituitary axis on the structure and function of the lacrimal gland. Adv. Exp. Med. Biol. 438:11-45, 1998.
5. Lemp, M.A. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J. 21:221-232, 1995.
6. Dartt, D.A. Signal transduction and control of lacrimal gland protein secretion: a review. Curr. Eye. Res. 8:619-636, 1989.
7. Ding, C., Walcott, B. and Keyser, K.T. Neuronal and endothelial nitric oxide synthase are expressed in mouse lacrimal gland. Invest. Ophthalmol. Vis. Sci. 41:S61, 2000.
8. Hann, L.E., Tatro, J.B., and Sullivan, D.A. Morphology and function of lacrimal gland acinar cells in primary culture. Invest. Ophthalmol. Vis. Sci. 30:145-158, 1989.
9. Meneray, M.A., Fields, T.Y., Bromberg, B.B., and Moses, R.L. Morphology and physiologic responsivesness of cultured rabbit lacrimal acini. Invest. Ophthalmol. Vis. Sci. 35:4144-4158, 1994.
10. Rismondo, V., Gierow, J.P., Lambert, R.W., Golchini, K., Feldon, S.E., and Mircheff, A.K. Rabbit lacrimal acinar cells in primary culture: morphology and acute responses to cholinergic stimulation. Invest. Ophthalmol. Vis. Sci. 35:1176-1183, 1994.
11. Nguyen, D.H., Beuerman, R.W., Halbert, C.L., Ma, Q. and Sun, G. Characterization of immortalized lacrimal gland epithelial cells. In Vitro Cell Dev. Biol.-Animal 35:198-204, 1999.
12. Saarloos, M-N, Husa, M.R., Jackson, R.S., and Ubels, J.L. Intermediate filament, laminin and integrin expression in lacrimal gland acinar cells: comparison of an immortalized cell line to primary cells, and their response to retinoic acid. Curr. Eye Res. 19:439-449, 1999.
13. Fox, R.I. Sjögren's syndrome: Pathogenesis and new approaches to therapy. Adv. Exp. Med. Biol. 438:891-902, 1998.
14. 2+ in potentiation of rat lacrimal gland protein secretion. Invest. Ophthalmol. Vis. Sci. 29:1732-1738, 1988.
15. Fox, R.I. and Michelson, P. Approaches to the treatment of Sjögren's syndrome. J. Rheumatol. Suppl. 61:15-21, 2000.
16. Physician's Desk Reference, 56th Edition, Medical Economics Company, Montvale, New Jersey, 2002.
17. Colasant, M., and Suzuki, H. The dual personality of NO. Trends Pharmacol. Sci. 21:249-251, 2000.
18. Ignarro, L.J. Nitric oxide as a communication signal in vascular and neuronal cells. Nitric Oxide: Principles and Actions Lancaster, J., ed.: 111-137, 1996.
19. Lander, H.M., and Deora, A. Role for nitric oxide and other radicals in signal transduction. Nitric Oxide: Biology and Pathobiology Ignarro, L.J., ed.: 251-264, 2000.
20. Murphy, M.P. Nitric oxide and cell death. Biochim. Biophys. Acta. 1411:401-414, 1999.
21. Kroncke, K.D., Fehsel, K., and Kolb-Bachofen, V. Nitric oxide: cytotoxicity versus cytoprotection - how, why, when, and where? Nitric Oxide 1:107-120, 1997.
22. Adeghate, E., and Parvez, S.H. Nitric oxide and neuronal and pancreatic beta cell death. Toxicology 153:143-156, 2000.
23. Titheradge, M.A. Nitric oxide in septic shock. Biochem. Biophys. Acta 1411:437-455, 1999.
24. Beauregard, C., Brandt, P.C., and Chiou, G.C.Y. Introduction of nitric oxide synthase and over-production of nitric oxide by interleukin-Iβ in cultured lacrimal gland acinar cells. Exp. Eye Res. in press, 2002.
25. Lemp, M.A. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J. 21:221-232 1995.
26. Chiou, G.C.Y. Interleukin-1 blockers: a new class of nonarachidonate, nonsteroidal anti-inflammatory drugs. Drugs of the Future 24:979-990, 1999.
27. Chiou, G.C.Y., and Liu, S.X.L. Systemic anti-inflammation by synthetic interleukin-1 blockers. Acta Pharmacologica Sinica 20:405-408, 1999.